Efficacy of Ompatrilat in Patients with Hypertension and Atherosclerotic Disease - OCTAVE Substudy

Description:

Substudy of the OCTAVE trial comparing the vasopeptidase inhibitor, ompatrilat, to enalapril in control of hypertension.